Threshold Pharmaceuticals thresholdpharm.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show all

Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certa...Show all

Company (Merged)

Phone: 650-474-8200

Fax:

1300 Seaport Boulevard
Suite 500
Redwood City, 94063
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Threshold Pharmaceuticals $69.1M Aug 2, 2017
Trevena $188.5M Jan 31, 2014
Arcion Therapeutics $17M Oct 1, 2012
See all 75 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Threshold Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors

Competitors

Company Status Description Investors
See all 75 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer Dec 20, 2012 Feb 09, 2016 Patent
Phosphoramidate alkylator prodrugs Dec 10, 2013 Jan 05, 2016 Patent
Anti-cancer therapies Oct 23, 2012 Dec 08, 2015 Patent
Treatment of cancer using hypoxia activated prodrugs Oct 21, 2009 Feb 03, 2015 Patent
Treatment of cancer with glufosfamide in patients not receiving insulin therapy Apr 07, 2008 Jul 01, 2014 Patent
See all 24 patents